348.38
+26.81
+(8.34%)
At close: January 31 at 10:31:48 AM GMT-3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 24 | 35 | 34 |
| Avg. Estimate | 9.55B | 9.88B | 39.57B | 43.69B |
| Low Estimate | 9.33B | 9.71B | 39.2B | 42.59B |
| High Estimate | 9.67B | 10.11B | 40.04B | 45.24B |
| Year Ago Sales | 8.78B | 8.9B | 35.93B | 39.57B |
| Sales Growth (year/est) | 8.84% | 10.97% | 10.15% | 10.42% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| V.SN | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 1/31/2025 |
| Maintains | UBS: Buy to Buy | 1/31/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 1/31/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 1/31/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 1/31/2025 |
| Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/31/2025 |